false 0001420520 0001420520 2024-04-25 2024-04-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares









Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of report (Date of earliest event reported): April 25, 2024





(Exact Name of Registrant as Specified in Its Charter)




Delaware 001-37850 30-0509586
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number)


750 University Avenue, Suite 280

Los Gatos, California 95032

(Address of principal executive offices)


(408) 442-5248

(Registrant’s telephone number, including area code)




(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock: Par value $0.001   ATOM   Nasdaq Capital Markets


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 2.02 Results of Operations and Financial Condition


On April 25, 2024, Atomera Incorporated issued a press release announcing its financial results for the three months ended March 31, 2024. The Company also intends to conduct an earnings call over which it will distribute an investor presentation. The text of the press release is attached hereto as Exhibit 99.1 and the investor presentation is attached hereto as Exhibit 99.2, both are incorporated by reference herein.


The information in this Current Report, including the exhibits attached hereto, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act regardless of any general incorporation language in such filing.


Item 9.01 Financial Statements and Exhibits


(d) Exhibits  


The following exhibits are filed with this report:


Exhibit Number Exhibit Description
99.1 Press release dated April 25, 2024 Atomera Incorporated
99.2 Investor presentation dated April 25, 2024 Atomera Incorporated
104 Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101).















Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.


Dated: April 25, 2024 /s/ Francis B. Laurencio  

Francis B. Laurencio,

Chief Financial Officer




















Exhibit 99.1





Atomera Provides First Quarter 2024 Results


LOS GATOS, Calif. April 25, 2024 Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2024.


Recent Company Highlights


·Strong progress with customers in all four market focus segments
·Record number of commercial proposals in the last three months
·Promising GaN results in a new product category, Compound Semiconductors


Management Commentary


“As our first commercial customer continues on the path to production, we have been more active on license agreements with other customers than at any time in our history,” said Scott Bibaud, President and CEO. “We believe this proposal activity, combined with our potential to enter the compound semiconductor market segment will provide sustaining growth on top of a solid foundation to build Atomera into a premier leader in the semiconductor industry.”


Financial Results


The Company incurred a net loss of ($4.8) million, or ($0.19) per basic and diluted share in the first quarter of 2024, compared to a net loss of ($5.0) million, or ($0.21) per basic and diluted share, for the first quarter of 2023. Adjusted EBITDA (a non-GAAP financial measure) in the first quarter of 2024 was a loss of ($4.0) million compared to an adjusted EBITDA loss of ($4.2) million in the first quarter of 2023.


The Company had $19.3 million in cash, cash equivalents and short-term investments as of March 31, 2024, compared to $19.5 million as of December 31, 2023.


The total number of shares outstanding was 26.9 million as of March 31, 2024.


First Quarter 2024 Results Webinar


Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Thursday, April 25, 2024

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com


Note about Non-GAAP Financial Measures


In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.






About Atomera Incorporated


Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap.  More information can be found at www.atomera.com.  


Safe Harbor


This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) the risk that STMicroelectronics does not proceed with qualification of MST in its manufacturing process or does not take MST-enabled products to market, (3) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a commercial distribution license with our JDA customers; (4) risks related to our ability to advance licensing arrangements with our integration licensees to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (5) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (6) our ability to protect our proprietary technology, trade secrets and knowhow and (7) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 15, 2024. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.


-- Financial Tables Follow –









Atomera Incorporated

Condensed Balance Sheets

(in thousands, except per share data)


   March 31,   December 31, 
   2024   2023 
Current assets:          
Cash and cash equivalents  $14,806   $12,591 
Short-term investments   4,458    6,940 
Unbilled contracts receivable       550 
Interest receivable   73    79 
Prepaid expenses and other current assets   328    244 
Total current assets   19,665    20,404 
Property and equipment, net   83    100 
Long-term prepaid maintenance and supplies   91    91 
Security deposit   14    14 
Operating lease right-of-use asset   459    517 
Financing lease right-of-use-asset   2,622    2,903 
Total assets  $22,934   $24,029 
Current liabilities:          
Accounts payable  $601   $618 
Accrued expenses   210    222 
Accrued payroll related expenses   454    1,382 
Current operating lease liability   263    264 
Current financing lease liability   1,357    1,328 
Deferred revenue   17     
Total current liabilities   2,902    3,814 
Long-term operating lease liability   194    295 
Long-term financing lease liability   1,431    1,750 
Total liabilities   4,527    5,859 
Commitments and contingencies        
Stockholders’ equity:          
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31 2024 and December 31, 2023        
Common stock: $0.001 par value, authorized 47,500 shares; 26,905 shares issued and 26,885 outstanding as of March 31, 2024; and 26,107 shares issued and outstanding as of December 31, 2023   27    26 
Additional paid in capital   226,288    221,229 
Other comprehensive income (loss)   (1)    
Accumulated deficit   (207,907)   (203,085)
Total stockholders’ equity   18,407    18,170 
Total liabilities and stockholders’ equity  $22,934   $24,029 







Atomera Incorporated

Condensed Statements of Operations

(in thousands, except per share data)



   Three Months Ended 
   March 31,   December 31,   March 31, 
   2024   2023   2023 
Revenue  $18   $550   $ 
Cost of revenue   (33)   (28)    
Gross margin (loss)   (15)   522     
Operating expenses               
Research and development   2,858    2,992    3,036 
General and administrative   1,811    1,875    1,742 
Selling and marketing   350    452    389 
Total operating expenses   5,019    5,319    5,167 
Loss from operations   (5,034)   (4,797)   (5,167)
Other income (expense)               
Interest income   205    195    199 
Accretion income   46    62    2 
Other income (expense), net       3     
Interest expenses   (39)   (43)   (53)
Total other income (expense), net   212    217    148)
Net loss  $(4,822)  $(4,580)  $(5,019)
Net loss per common share, basic and diluted  $(0.19)  $(0.18)  $(0.21)
Weighted average number of common shares outstanding, basic and diluted   26,038    25,404    23,660 








Atomera Incorporated

Reconciliation to Non-GAAP EBITDA



   Three Months Ended 
   March 31,   December 31,   March 31, 
   2024   2023   2023 
Net loss (GAAP)  $(4,822)  $(4,580)  $(5,019)
Depreciation and amortization   17    17    20 
Stock-based compensation   1,024    1,015    927 
Interest income   (205)   (195)   (199)
Accretion income   (46)   (62)   (2)
Other (income) expense, net       (3)    
Interest expense   39    43    53 
Net loss non-GAAP EBITDA  $(3,993)  $(3,765)  $(4,220)





Investor Contact:

Bishop IR

Mike Bishop

(415) 894-9633








Exhibit 99.2


Q1 2024 Conference Call April 25, 2024 Atomera Incorporated 1


Safe Harbor This presentation contains forward - looking statements concerning Atomera Incorporated (““Atomera,” the “Company,” “we,” “us,” and “our”). The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “woul d,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forwar d - looking statements. These forward - looking statements are subject to a number of risks, uncertainties and assumptions, including those disclosed in the section "Risk Factors" included in our Annual Report on Form 10 - K filed with the SEC on February 15, 2024 (the “Annual Report ”). In light of these risks, uncertainties and assumptions, the forward - looking events and circumstances discussed in this presentation may not occur and actual results could differ materially and adversely from those anticipated or implied in our forward - looking statements. You should not rely upon forward - looking statements as predictions of future events. Although we believe that the expectations reflected in our forward - looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward - looking statements will be achieved or occur. This presentation contains only basic information concerning Atomera. The Company’s filings with the Securities Exchange Commission, including the Annual Report, include more information about factors that could affect the Company’s operating and financial results. We assume no obligation to update information contained in this presentation. Although this presentation m ay remain available on the Company's website or elsewhere, its continued availability does not indicate that we are reaffirming or confirming any of the information contained herein. Atomera Incorporated 2


3 Strong, Growing and Defensible Patent Portfolio High Leverage IP Licensing Business Model Top Tier Management Team Transistor enhancement technology for the $550B semiconductor market Mears Silicon Technology (MST®) Quantum Engineered Materials


Customer Pipeline 4 • 20 customers, 26 engagements • Working with 50% of the world’s top semiconductor makers* • 10 of the top 20 (IC Insights, McClean Report 2023) ^ End of year engagement count Atomera Incorporated Customer Wafer Manufacturing v Customer MST ® Deposition Atomera MST ® Deposition 6 . Production 5 . Qualification 4 . Installation 3 . Integration 2 . Setup 1 . Planning Phase 0 3 6 9 12 15 18 21 24 27 2016 2017 2018 2019 2020 2021 2022 2023 Q124 Number of Customer Engagements Phase 1 Phase 2 Phase 3 Phase 4


MST technology focus areas Atomera 5 MST for Advanced Nodes MST for RF - SOI MST for Power SP, SPX MST for DRAM


Compound Semiconductors ► Compound semiconductor market growing rapidly ▪ GaN is one example ► Poor wafer substrate quality causes manufacturing challenges ► Atomera’s MST may help to solve this problem ► Early experiments of GaN on MST show promising results Atomera 6


Financial Review Atomera Incorporated 7 Income Statement ($ in thousands, except per-share data) March 31, 2024 December 31, 2023 March 31, 2023 REVENUE 18$ 550$ -$ Gross Profit (15) 522 - OPERATING EXPENSES Research & Development 2,858 2,992 3,036 General and Administration 1,811 1,875 1,742 Selling and Marketing 350 452 389 TOTAL OPERATING EXPENSES 5,019 5,319 5,167 OPERATING LOSS (5,034) (4,797) (5,167) Other Income (Expense) 212 217 148 Provision for income tax - - - NET LOSS (4,822)$ (4,580)$ (5,019)$ Net Loss Per Share (0.19)$ (0.18)$ (0.21)$ Weighted average shares outstanding 26,038 25,404 23,660 ADJUSTED EBITDA (NON-GAAP) (3,993)$ (3,765)$ (4,220)$ ADJUSTED EBITDA PER SHARE (0.15)$ (0.15)$ (0.18)$ Balance Sheet Information Cash, equivalents & ST investments 19,264$ 19,531$ 17,052$ Debt - - - Three Months Ended


We collaborate with customers to improve their products, through integration of MST, so that both companies benefit financially Mission Statement Atomera Incorporated 8


Thank You Atomera Incorporated 9